Showing 771-780 of 1614 results for "".
- Ziemer Receives CE Mark Clearance For Two New Applications For the Femto LDV Z8 Laser Platformhttps://modernod.com/news/ziemer-receives-ce-mark-clearance-for-two-new-applications-for-the-femto-ldv-z8-laser-platform/2477654/After several years of development, Ziemer has received CE clearance for its new lenticule application called CLEAR (Corneal Lenticule Extraction for Advanced Refractive Correction). The new proprietary application is
- Zeiss Marks Milestone for its New North America High Tech Site in Dublin, Californiahttps://modernod.com/news/zeiss-marks-milestone-for-its-new-north-america-high-tech-site-in-dublin-california/2476730/Zeiss announced that it has completed the “steel topping out” phase of its new high tech site in the San Francisco Bay Area. The new center will encompass 208,650 square feet with three floors. It is scheduled for completion in the fourth quarter of 2020 and will bring together multiple Ze
- Emily Chew, MD, Named NIH Distinguished Investigatorhttps://modernod.com/news/emily-chew-md-named-nih-distinguished-investigator/2481980/Emily, Chew, MD, has been promoted to the title of NIH Distinguished Investigator for her work as a care provider and clinical trialist. Dr. Chew directs National Eye Institute's Division of Epidemiology and Clinical Applications (DECA). An ophthalmologist, she specializes in c
- Julia A. Haller, MD, Elected to National Academy of Medicinehttps://modernod.com/news/julia-a-haller-md-elected-to-national-academy-of-medicine/2477033/Wills Eye Hospital announced its Ophthalmologist-in-Chief, Julia A. Haller, MD, has been elected to the National Academy of Medicine (NAM), considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstanding professional achievement
- Pioneering Ophthalmologist Patricia Bath, MD, Dies at 76https://modernod.com/news/pioneering-ophthalmologist-patricia-bath-md-dies-at-76/2476632/Patricia E. Bath, MD, an ophthalmologist who took a special interest in combating preventable blindness in underserved populations and became the first black female doctor to patent a medical invention, a laser device for treating cataracts, died at the age of 76, acc
- Alimera Sciences Appoints David Dyer, MD, as Chief Retina Specialisthttps://modernod.com/news/alimera-sciences-appoints-david-dyer-md-as-chief-retina-specialist/2479222/Alimera Sciences has announced the expansion of its leadership team with the appointment of David Dyer, MD, as chief retina specialist, effective today. Dr. Dyer brings his extensive medical knowledge and business exp
- UK’s First TransForm Inlay Procedure Performed by Sheraz Daya, MDhttps://modernod.com/news/uks-first-transform-inlay-procedure-performed-by-sheraz-daya-md/2476668/The first patients in the UK have undergone the TransForm Corneal Allograft (TCA) procedure, which was performed by Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth. TCA is a new procedur
- Ophthalmic World Leaders (OWL) Names First MD President and Other Leadership Changes for 2026https://modernod.com/news/ophthalmic-world-leaders-owl-names-first-md-president-and-other-leadership-changes-for-2026/2484293/Ophthalmic World Leaders (OWL) announces the appointment of Renee Bovelle, MD, as its new President. OWL also welcomes three new members to its Board of Directors: Kevin M. Douglas, MD (Medical Director, Eye Care – Retina, AbbVie), Maáza Martin (S
- Geoff Tabin, MD, Co-Founder of Global NGO HCP Cureblindness, Steps Into New Rolehttps://modernod.com/news/geoff-tabin-md-co-founder-of-global-ngo-hcp-cureblindness-steps-into-new-role/2482314/Effective immediately, Geoff Tabin, MD, will step down as Board Chair of the global nonprofit HCP Cureblindness (Himalayan Cataract Project), but will maintain an active role on the Board as Medical Director. Long-time HCP volunteer and Board Member, Matt Oliva, MD, will lead HCP into its excitin
- Azura Ophthalmics Enrolls First Patient in Phase 3 Clinical Trial for AZR-MD-001 in Patients with MGDhttps://modernod.com/news/azura-ophthalmics-enrolls-first-patient-in-phase-3-clinical-trial-for-azr-md-001-in-patients-with-mgd/2482307/Azura Ophthalmics announced that the first patient has been enrolled in the ASTRO study—a phase 3 clinical trial assessing the efficacy and safety of AZR-MD-001 in patients with clinical signs and symptoms of meibomian gland dysfunction (MGD). "AZR-MD-001 has already dem